NR4A1 and neoplasm: The Nagelkerke R2 of 0.410 indicates that the model explained a substantial portion of the variance in achieving significant regression, suggesting that US measurements combined with specific tumor characteristics (e.g., hormone receptor status) can be used to predict treatment outcomes with reasonable accuracy.